| Thu 5 Apr 2012, 12:30 | | CMP - Cipla Medpro South Africa Limited - Declaration of ordinary dividend |
|
CMP
CMP
CMP - Cipla Medpro South Africa Limited - Declaration of ordinary dividend
CIPLA MEDPRO SOUTH AFRICA LIMITED
Registration number: 2002/018027/06
JSE code: CMP
ISIN: ZAE000128179
("Cipla Medpro")
DECLARATION OF ORDINARY DIVIDEND
Shareholders are referred to the reviewed condensed consolidated annual
results for the year ended 31 December 2011 released on SENS on 15 March 2012
and are advised that the board has now declared a final dividend of 7,5 cents
per share (gross) in respect of the 2011 financial year. The dividend has
been declared out of income reserves.
This will bring the total cash dividend to 14,0 cents per share for the 2011
financial year, an increase of 27,3% when compared to the total dividend of
11,0 cents in 2010.
The salient dates for the payment of the final dividend are detailed below:
Last day to trade cum dividend Friday, 4 May 2012
Shares trade ex dividend Monday, 7 May 2012
Record date Friday, 11 May 2012
Payment date Monday, 14 May 2012
Share certificates may not be dematerialised or rematerialised between
Monday, 7 May 2012 and Friday, 11 May 2012, both dates inclusive.
In terms of the new Dividends Tax effective 1 April 2012, the following
additional information is disclosed:
The local dividend tax rate is 15%;
There are no STC credits utilised;
The net local dividend amount is 6,3750 cents per share for shareholders
liable to pay the new Dividends Tax and 7,5000 cents per share for
shareholders exempt from paying the new Dividends Tax;
The issued share capital of Cipla Medpro is 446 461 759 ordinary shares; and
Cipla Medpro`s tax reference number is 9987069144.
5 April 2012
Sponsor
Nedbank Capital
Date: 05/04/2012 12:30:01 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
